• Company
• SK Chemical ‘will continue pharma business without selling'
• by Kim, Jin-Gu Feb 15, 2024 05:58am

• Company
• Statin+ezetimibe combo mkt size nears ₩1 tril in KOR
• by Chon, Seung-Hyun Feb 15, 2024 05:58am

• Policy
• The guidelines for PVA will be revised soon
• by Lee, Tak-Sun Feb 15, 2024 05:58am

• Policy
• Price cut hold for Forxiga, Xigduo, Atmeg Combi are extended
• by Lee, Jeong-Hwan Feb 14, 2024 05:40am

• Policy
• Chinese MM drug Xpovio reattempts reimb listing in KOR
• by Lee, Tak-Sun Feb 14, 2024 05:40am

• Company
• SK Chemical’s pharma biz recorded sales of 376.1 bil. won
• by Chon, Seung-Hyun Feb 14, 2024 05:40am

• Company
• Market for Pulmicort and Pulmican soars 2.6 times in 2 years
• by Chon, Seung-Hyun Feb 14, 2024 05:40am

• Policy
• Will Enhertu·Ilaris·morning sickness drugs be reimbursed
• by Lee, Tak-Sun Feb 14, 2024 05:40am

• Company
• Unstoppable sales growth of Entresto
• by Kim, Jin-Gu Feb 13, 2024 06:18am

• Policy
• HIRA to revise guidelines on new drugs utility assessment
• by Lee, Tak-Sun Feb 13, 2024 05:52am